I am a Sr. Director of Pharmacometrics/clinical pharmacology, heavily involved in advancing the use of quantitative analysis in the drug development process from preclinical to clinical. I firmly believe that such approach in the drug development process offers a rational methodology in bringing new products faster to the market. Furthermore, my recent MBA degree (2015) has been helpful in understanding the business side of the biotech industry, an area I have been interested in for a while.
Feel free to browse my site, take a look at my resume and list of publications. |
 |